![5-(5-Chlorosulfonyl-2-ethoxyphenyl)-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one](https://manusakttevabiopharma.com/wp-content/uploads/2021/12/139756-22-2.jpg)
We are offering the product from our Indian manufacturer’s USFDA, Japan PMDA, Korea FDA approved site. Their facility is COFEPRIS inspected for several products. Their R&D facility is recognized by the Department of Scientific and Industrial Research (DSIR, Ministry of Science and Technology, Government of India).
5-(5-Chlorosulfonyl-2-ethoxyphenyl)-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one
Additional information
| Product Name | 3-d]pyrimidin-7-one, 5-(5-Chlorosulfonyl-2-ethoxyphenyl)-1-methyl-3-propyl-1, 6-dihydro-7H-pyrazolo[4 |
|---|---|
| CAS Registry No | 139756-22-2 |
| Specification | In-House |
| Synonyms | 3-d]pyrimidin-5-yl)benzene-1-sulfonyl chloride, 4-Ethoxy-3-(6, 7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4 |
| Molecular Formula | C17H19ClN4O4S |
| Molecular Weight | 410.88 |
| MSDS Description | Available on request |
| Availability | For Research and Development Purpose |
| Application | Erectile Dysfunction |
![1-[4-(Chloromethyl)-1,3-thiazol-2-yl]guanidine hydrochloride (1:1)](https://manusakttevabiopharma.com/wp-content/uploads/2021/12/69014-12-6.jpg)
